SurgePays Inc.

2.67
0.18 (7.23%)
At close: Apr 21, 2025, 3:59 PM
2.62
-1.69%
Pre-market: Apr 22, 2025, 06:18 AM EDT

SurgePays Statistics

Share Statistics

SurgePays has 20.41M shares outstanding. The number of shares has increased by 5.15% in one year.

Shares Outstanding 20.41M
Shares Change (YoY) 5.15%
Shares Change (QoQ) 1.24%
Owned by Institutions (%) 10.06%
Shares Floating 14.12M
Failed to Deliver (FTD) Shares 75.08K
FTD / Avg. Volume 4.59%

Short Selling Information

The latest short interest is 1.43M, so 6.99% of the outstanding shares have been sold short.

Short Interest 1.43M
Short % of Shares Out 6.99%
Short % of Float 9.67%
Short Ratio (days to cover) 1

Valuation Ratios

The PE ratio is -0.74 and the forward PE ratio is 1.78. SurgePays's PEG ratio is 0.

PE Ratio -0.74
Forward PE 1.78
PS Ratio 0.56
Forward PS 0.2
PB Ratio 2.22
P/FCF Ratio -1.56
PEG Ratio 0
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for SurgePays.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.95, with a Debt / Equity ratio of 0.1.

Current Ratio 2.95
Quick Ratio 2.66
Debt / Equity 0.1
Debt / EBITDA -0.04
Debt / FCF -0.07
Interest Coverage -75.39

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $468.32K
Profits Per Employee $-351.76K
Employee Count 130
Asset Turnover 2.54
Inventory Turnover 42.22

Taxes

Income Tax 2.87M
Effective Tax Rate -6.66%

Stock Price Statistics

The stock price has increased by -21.7% in the last 52 weeks. The beta is 1.13, so SurgePays's price volatility has been higher than the market average.

Beta 1.13
52-Week Price Change -21.7%
50-Day Moving Average 1.67
200-Day Moving Average 1.87
Relative Strength Index (RSI) 70.47
Average Volume (20 Days) 1.64M

Income Statement

In the last 12 months, SurgePays had revenue of 60.88M and earned -45.73M in profits. Earnings per share was -2.39.

Revenue 60.88M
Gross Profit -14.32M
Operating Income -41.78M
Net Income -45.73M
EBITDA -41.22M
EBIT -42.51M
Earnings Per Share (EPS) -2.39
Full Income Statement

Balance Sheet

The company has 11.79M in cash and 1.51M in debt, giving a net cash position of 10.28M.

Cash & Cash Equivalents 11.79M
Total Debt 1.51M
Net Cash 10.28M
Retained Earnings -60.92M
Total Assets 23.98M
Working Capital 11.81M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -21.31M and capital expenditures -518.19K, giving a free cash flow of -21.83M.

Operating Cash Flow -21.31M
Capital Expenditures -518.19K
Free Cash Flow -21.83M
FCF Per Share -1.14
Full Cash Flow Statement

Margins

Gross margin is -23.53%, with operating and profit margins of -68.63% and -75.11%.

Gross Margin -23.53%
Operating Margin -68.63%
Pretax Margin -70.74%
Profit Margin -75.11%
EBITDA Margin -67.71%
EBIT Margin -68.63%
FCF Margin -35.85%

Dividends & Yields

SURG does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for SURG is $8.5, which is 218.4% higher than the current price. The consensus rating is "Buy".

Price Target $8.5
Price Target Difference 218.4%
Analyst Consensus Buy
Analyst Count 1
Stock Forecasts

Stock Splits

The last stock split was on Nov 2, 2021. It was a backward split with a ratio of 1:50.

Last Split Date Nov 2, 2021
Split Type backward
Split Ratio 1:50

Scores

Altman Z-Score -2.82
Piotroski F-Score 2